News & Events
Nanopharm News & Events
Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.
18 July 2025
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.
Filter Resources By
01 Oct 2022
Aptar Pharma, OINDP, PBPK, PBPK models
11 May 2022
Biologics, COVID-19, Nasal, Nasal Delivery, therapeutics
15 Apr 2022
drug formulation, formulation and development, Nasal
14 Apr 2022
Biologics, drug delivery, Drug Development, Nanopharm, Nasal, SARS-CoV-2
06 Apr 2022
environmental footprint, Global Warming Potential, MDIs, metered dose inhalers, SmartTrack
01 Apr 2022
Aptar Pharma, drug delivery, Nasal
01 Apr 2022
drug formulation, formulation and development, Nasal
09 Dec 2021
Biologics Characterization, cGMP, Drug Development, Nanopharm, OINDP, Particle Engineering
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
21 Jul 2021
Drug Development, Intranasal Spray, Leyden Labs, Nanopharm, OINDP, Respiratory Viruses